No Data
Mizuho Securities Maintains Biogen(BIIB.US) With Buy Rating
Sage To Resume Full Ownership Of SAGE-324 Program As Biogen Terminates Collaboration Deal
Sage Therapeutics, Biogen End Licensing Agreement for Tremor Drug
Biogen to End Sage Deal for Neuro Candidate
Express News | Sage Therapeutics Announces Discontinuation of the Collaboration With Biogen on the Sage-324 Program
Sage Therapeutics Announces Discontinuation of the Collaboration With Biogen on the SAGE-324 Program
webguybob : The Etsy downgrade surprised me!
105535782 : ok
102242135 Lim : K